source
- AbbVie faces questions about Skyrizi competition from J&JThreats to AbbVie's immunology dominance took center stage on the company's first-quarter earnings call Wednesday morning, as analysts pressed executives on their defense strategy. The heart of the…Endpoints · 3mo ago↗ source
- FDA, AstraZeneca prep for oncology adcommThe FDA is set to convene its first advisory meeting of oncology experts in about nine months, with a couple of AstraZeneca drugs as the focus of the discussion. Details about the meeting of the ...Endpoints · 3mo ago↗ source
- STAT+: Why conversations around health AI may be evolving beyond hypeIn this edition of AI Prognosis, Brittany Trang argues that the tide may be turning when it comes to how the health care industry talks about AI.STAT · 3mo ago